Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study

Journal of the American Academy of Dermatology

Volumn 47, Issue 2, 2002, Pages 258-262

  Szeimies, R M ^a   Karrer, S ^a   Radakovic Fijan, S ^b   Tanew, A ^b   Calzavara Pinton, P G ^c   Zane, C ^c   Sidoroff, A ^d   Hempel, M ^e   Ulrich, J ^f   Proebstle, T ^g   Meffert, H ^h   Mulder, M ⁱ   Salomon, D ^j   Dittmar, H C ^k   Bauer, J W ^l   Kernland, K ^m   Braathen, L ^m  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF VIENNA   (Austria)

^c Spedali Di Civili   (Italy)

^d UNIVERSITY OF INNSBRUCK   (Austria)

^e UNIVERSITY HOSPITAL BASEL   (Switzerland)

^f OTTO VON GUERICKE UNIVERSITY   (Germany)

^g JOHANNES GUTENBERG UNIVERSITY   (Germany)

^h CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

ⁱ UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^j GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^k UNIVERSITY OF FREIBURG   (Germany)

^l Salzburger Landeskliniken   (Austria)

^m UNIVERSITY OF BERN   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; LIQUID NITROGEN; METHYL 5 AMINOLEVULINIC ACID; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG;

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYOTHERAPY; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT SATISFACTION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RED LIGHT; TREATMENT OUTCOME;

EID: 0036697139     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2002.119649     Document Type: Article

References (12)

1. Drake LA, Ceilley RI, Cornelison RL, Dobes WL, Dorner W, Goltz RW, et al. Guidelines of care for actinic keratoses. J Am Acad Dermatol 1995;32:95-8.
2. Zouboulis CC. Cryosurgery in dermatology. EurJ Dermatol 1998; 8:466-74.
3. Dinehart SM. The treatment of actinic keratoses. J Am Acad Dermatol 2000;42(Suppl):S25-8.
4. Lubritz RR, Smolewski PA-C. Cryosurgery cure rate of actinic keratoses. J Am Acad Dermatol 1982;7:631-2.
5. Jeffes EW, McCullough JL, Weinstein GD, Fergin PE, Nelson JS, Shull TF, et al. Photodynamic therapy of actinic keratosis with topical 5-aminolevulinic acid. Arch Dermatol 1997;133:727-32.
6. Szeimies RM, Karrer S, Sauerwald A, Landthaler M. Photodynamic therapy with topical application of 5-aminolevulinic acid in the treatment of actinic keratoses: an initial clinical study. Dermatology 1996;192:246-51.
7. Fink-Puches R, Hofer A, Smolle J, Kerl H, Wolf P. Primary clinical response and long-term follow-up of solar keratoses treated with topically applied 5-aminolevulinic acid and irradiation by different wave bands of light. J Photochem Photobiol B Biol 1997;41:145-51.
8. Peng Q, Moan J, Warloe T, Iani V, Steen HB, Bjorseth A, et al. Build-up of esterified aminolevulinic-acid-derivative-induced porphyrin fluorescence in normal mouse skin. J Photochem Photobiol B Biol 1996;34:95-6.
9. Kloek J, Beijersbergen van Henegouwen GMJ. Prodrugs of 5-aminolevulinic acid for photodynamic therapy. Photochem Photobiol 1996;64:994-1000.
10. Fritsch C, Homey B, Stahl W, Lehmann P, Ruzicka T, Sies H. Preferential relative porphyrin enrichment in solar keratoses upon topical application of δ-aminolevulinic acid methylester. Photochem Photobiol 1998;68:218-21.
11. Olsen EA, Abernethy L, Kulp-Shorten C, Callen JP, Glazer SD, Huntley A, et al. A double-blind, vehicle-controlled study evaluating masoprostol cream in the treatment of actinic keratoses on the head and neck. J Am Acad Dermatol 1991;5:738-43.
12. Brand D, Ackerman AB. Squamous cell carcinoma, not basal cell carcinoma, is the most common in humans. J Am Acad Dermatol 2000;42:523-6.